_cathie-wood39s-ark-invest39s-third-largest-holding-is-this-little-known-biotech-company-harnessing-ai-for-drug-treatment.jpg "Cathie Wood's ARK Invest's Third-Largest Holding Is this Little Known Biotech Company Harnessing AI for Drug Treatments from an audio effect videoup v5 Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:40
👁 View: 710K times
✓ Published: 14-May-2024
👁 View: 710K times
✓ Published: 14-May-2024
Description:
Cathie Wood's ARK Invest has been buying shares of Recursion Pharmaceuticals, a biotech company using AI to speed up drug discovery. It is now the third-largest holding in her ARK Genomic Revolution ETF. Recursion has developed an AI-powered operating system that conducts up to 2.2 million weekly experiments to test drug candidates in an automated laboratory, advancing only the most promising compounds to clinical trials. Using AI this way could allow Recursion to launch drugs faster than competitors and license its OS to other companies, building a network effect that improves its algorithm over time.
Cathie Wood's ARK Invest has been buying shares of Recursion Pharmaceuticals, a biotech company using AI to speed up drug discovery. It is now the third-largest holding in her ARK Genomic Revolution ETF. Recursion has developed an AI-powered operating system that conducts up to 2.2 million weekly experiments to test drug candidates in an automated laboratory, advancing only the most promising compounds to clinical trials. Using AI this way could allow Recursion to launch drugs faster than competitors and license its OS to other companies, building a network effect that improves its algorithm over time.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
![[+]](/images/menu.gif){kind=small}